Literature DB >> 25231635

Rising like the phoenix?

Edward F Plow1, Mitali Das2.   

Abstract

Entities:  

Keywords:  platelet; platelet aggregation; thrombosis; αIIbβ3; αIIbβ3 antagonist

Mesh：

Substances：

Year:  2014        PMID： 25231635      PMCID： PMC4198940          DOI： 10.1161/ATVBAHA.114.304486

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN： 1079-5642            Impact factor:   8.311


× No keyword cloud information.
  17 in total

Review 1.  Understanding thrombocytopenia and antigenicity with glycoprotein IIb-IIIa inhibitors.

Authors:  M Madan; S D Berkowitz
Journal:  Am Heart J       Date:  1999-10       Impact factor: 4.749

Review 2.  Clinical challenges of platelet glycoprotein IIb/IIIa receptor inhibitor therapy: bleeding, reversal, thrombocytopenia, and retreatment.

Authors:  J E Tcheng
Journal:  Am Heart J       Date:  2000-02       Impact factor: 4.749

3.  Closed headpiece of integrin αIIbβ3 and its complex with an αIIbβ3-specific antagonist that does not induce opening.

Authors:  Jieqing Zhu; Jianghai Zhu; Ana Negri; Davide Provasi; Marta Filizola; Barry S Coller; Timothy A Springer
Journal:  Blood       Date:  2010-08-02       Impact factor: 22.113

4.  Translating from the rivers of Babylon to the coronary bloodstream.

Authors:  Barry S Coller
Journal:  J Clin Invest       Date:  2012-11-01       Impact factor: 14.808

Review 5.  Association of time to reperfusion with left ventricular function and heart failure in patients with acute myocardial infarction treated with primary percutaneous coronary intervention: a systematic review.

Authors:  Kashish Goel; Duane S Pinto; C Michael Gibson
Journal:  Am Heart J       Date:  2013-02-14       Impact factor: 4.749

6.  Weight of the bleeding impact on early and late mortality after percutaneous coronary intervention.

Authors:  Gjin Ndrepepa; Elena Guerra; Stefanie Schulz; Massimiliano Fusaro; Salvatore Cassese; Adnan Kastrati
Journal:  J Thromb Thrombolysis       Date:  2015-01       Impact factor: 2.300

7.  Fibrinogen receptor antagonist-induced thrombocytopenia in chimpanzee and rhesus monkey associated with preexisting drug-dependent antibodies to platelet glycoprotein IIb/IIIa.

Authors:  B Bednar; J J Cook; M A Holahan; M E Cunningham; P A Jumes; R A Bednar; G D Hartman; R J Gould
Journal:  Blood       Date:  1999-07-15       Impact factor: 22.113

Review 8.  Beyond heparin and aspirin: new treatments for unstable angina and non-Q-wave myocardial infarction.

Authors:  J I Weitz; S M Bates
Journal:  Arch Intern Med       Date:  2000-03-27

Review 9.  Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromes.

Authors:  Xavier Bosch; Jaume Marrugat; Juan Sanchis
Journal:  Cochrane Database Syst Rev       Date:  2010-09-08

Review 10.  Integrin αIIbβ3: from discovery to efficacious therapeutic target.

Authors:  Kamila Bledzka; Susan S Smyth; Edward F Plow
Journal:  Circ Res       Date:  2013-04-12       Impact factor: 17.367
View more
  2 in total

Review 1.  Platelets: Context-Dependent Vascular Protectors or Mediators of Disease.

Authors:  Randal Westrick; Gabrielle Fredman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-07       Impact factor: 8.311

Review 2.  Novel Antiplatelet Therapies for Atherothrombotic Diseases.

Authors:  Arjun Majithia; Deepak L Bhatt
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-04       Impact factor: 8.311
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.